These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1945416)
1. Occurrence of Ki-ras and p53 mutations in primary colorectal tumors. Shaw P; Tardy S; Benito E; Obrador A; Costa J Oncogene; 1991 Nov; 6(11):2121-8. PubMed ID: 1945416 [TBL] [Abstract][Full Text] [Related]
2. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression. De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895 [TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785 [TBL] [Abstract][Full Text] [Related]
4. Frequent p53 gene mutations in serrated adenomas of the colorectum. Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965 [TBL] [Abstract][Full Text] [Related]
6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
7. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746 [TBL] [Abstract][Full Text] [Related]
8. APC and p53 mutations in de novo colorectal adenocarcinomas. Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386 [TBL] [Abstract][Full Text] [Related]
9. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218 [TBL] [Abstract][Full Text] [Related]
10. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cote RJ; Jhanwar SC; Novick S; Pellicer A Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660 [TBL] [Abstract][Full Text] [Related]
11. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283 [TBL] [Abstract][Full Text] [Related]
13. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192 [TBL] [Abstract][Full Text] [Related]
14. [A joint study of mutation of the Ki-ras oncogene and overexpression of the Tp53 oncogene in colorectal cancer]. Laurent-Puig P; Delattre O; Olschwang S; Remvikos Y; Melot T; Salmon RJ; Frelat G; Thomas G Gastroenterol Clin Biol; 1990; 14(4):347-51. PubMed ID: 2190855 [TBL] [Abstract][Full Text] [Related]
15. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands. Van Den Broek MH; Renault B; Fodde R; Verspaget H; Griffioen G; Khan PM Anticancer Res; 1993; 13(3):587-92. PubMed ID: 8317886 [TBL] [Abstract][Full Text] [Related]
16. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester. Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090 [TBL] [Abstract][Full Text] [Related]
17. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507 [TBL] [Abstract][Full Text] [Related]
18. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Ichii S; Takeda S; Horii A; Nakatsuru S; Miyoshi Y; Emi M; Fujiwara Y; Koyama K; Furuyama J; Utsunomiya J Oncogene; 1993 Sep; 8(9):2399-405. PubMed ID: 8395678 [TBL] [Abstract][Full Text] [Related]
19. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830 [TBL] [Abstract][Full Text] [Related]
20. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]